Global Exosome Therapy Technology Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04258311

Publication Date:

April 15, 2025

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Exosome Therapy Technology market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Exosome therapy technology involves the use of exosomes, which are small extracellular vesicles secreted by various cell types, as therapeutic agents to treat various diseases and conditions. Exosomes are nanosized vesicles containing proteins, lipids, nucleic acids (including microRNAs), and other bioactive molecules. They play essential roles in cell-to-cell communication, and their unique properties make them promising candidates for therapeutic applications.
Exosome therapy technology has been gaining significant attention and interest from the medical and biopharmaceutical industries. The global market for exosome-based therapies has been steadily growing, driven by advancements in research and development, increasing understanding of exosome biology, and the potential of exosomes as promising therapeutic agents in various disease areas. The global market for exosome therapy technology is expected to continue its growth trajectory in the coming years. The field is likely to witness increased investments in research and development, clinical trials, and manufacturing capabilities. Advancements in exosome engineering, cargo loading, and targeting approaches are expected to enhance the therapeutic potential of exosomes for a wide range of diseases. Furthermore, as more companies and researchers enter the exosome therapeutics space, there is likely to be increased collaboration and partnerships to drive innovation and commercialization efforts. The market"s future growth will depend on successful clinical trials, regulatory approvals, and the ability to address the challenges associated with standardization and large-scale manufacturing.
LPI (publisher)' newest research report, the 鈥淓xosome Therapy Technology Industry Forecast鈥� looks at past sales and reviews total world Exosome Therapy Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Exosome Therapy Technology sales for 2025 through 2031. With Exosome Therapy Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapy Technology industry.
This Insight Report provides a comprehensive analysis of the global Exosome Therapy Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapy Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Exosome Therapy Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapy Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapy Technology.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapy Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Medical Treatement
Drug Delivery Vehicle
Others
Segmentation by Application:
Pharmaceutical Company
Hospital
Medical Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Codiak BioSciences
Capricor Therapeutics
Evox Therapeutics
ExoCarta
Aegle Therapeutics
Aruna Bio
NeuroTrauma Sciences
THERILLIA
Avalon GloboCare
CellTex Therapeutics
EVerZom
Lonza
ExoCoBio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Therapy Technology Market Size (2020-2031)
2.1.2 Exosome Therapy Technology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Exosome Therapy Technology by Country/Region (2020, 2024 & 2031)
2.2 Exosome Therapy Technology Segment by Type
2.2.1 Medical Treatement
2.2.2 Drug Delivery Vehicle
2.2.3 Others
2.3 Exosome Therapy Technology Market Size by Type
2.3.1 Exosome Therapy Technology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Exosome Therapy Technology Market Size Market Share by Type (2020-2025)
2.4 Exosome Therapy Technology Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Hospital
2.4.3 Medical Laboratory
2.4.4 Others
2.5 Exosome Therapy Technology Market Size by Application
2.5.1 Exosome Therapy Technology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Exosome Therapy Technology Market Size Market Share by Application (2020-2025)
3 Exosome Therapy Technology Market Size by Player
3.1 Exosome Therapy Technology Market Size Market Share by Player
3.1.1 Global Exosome Therapy Technology Revenue by Player (2020-2025)
3.1.2 Global Exosome Therapy Technology Revenue Market Share by Player (2020-2025)
3.2 Global Exosome Therapy Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Therapy Technology by Region
4.1 Exosome Therapy Technology Market Size by Region (2020-2025)
4.2 Global Exosome Therapy Technology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Exosome Therapy Technology Market Size Growth (2020-2025)
4.4 APAC Exosome Therapy Technology Market Size Growth (2020-2025)
4.5 Europe Exosome Therapy Technology Market Size Growth (2020-2025)
4.6 Middle East & Africa Exosome Therapy Technology Market Size Growth (2020-2025)
5 Americas
5.1 Americas Exosome Therapy Technology Market Size by Country (2020-2025)
5.2 Americas Exosome Therapy Technology Market Size by Type (2020-2025)
5.3 Americas Exosome Therapy Technology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Therapy Technology Market Size by Region (2020-2025)
6.2 APAC Exosome Therapy Technology Market Size by Type (2020-2025)
6.3 APAC Exosome Therapy Technology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Therapy Technology Market Size by Country (2020-2025)
7.2 Europe Exosome Therapy Technology Market Size by Type (2020-2025)
7.3 Europe Exosome Therapy Technology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Therapy Technology by Region (2020-2025)
8.2 Middle East & Africa Exosome Therapy Technology Market Size by Type (2020-2025)
8.3 Middle East & Africa Exosome Therapy Technology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exosome Therapy Technology Market Forecast
10.1 Global Exosome Therapy Technology Forecast by Region (2026-2031)
10.1.1 Global Exosome Therapy Technology Forecast by Region (2026-2031)
10.1.2 Americas Exosome Therapy Technology Forecast
10.1.3 APAC Exosome Therapy Technology Forecast
10.1.4 Europe Exosome Therapy Technology Forecast
10.1.5 Middle East & Africa Exosome Therapy Technology Forecast
10.2 Americas Exosome Therapy Technology Forecast by Country (2026-2031)
10.2.1 United States Market Exosome Therapy Technology Forecast
10.2.2 Canada Market Exosome Therapy Technology Forecast
10.2.3 Mexico Market Exosome Therapy Technology Forecast
10.2.4 Brazil Market Exosome Therapy Technology Forecast
10.3 APAC Exosome Therapy Technology Forecast by Region (2026-2031)
10.3.1 China Exosome Therapy Technology Market Forecast
10.3.2 Japan Market Exosome Therapy Technology Forecast
10.3.3 Korea Market Exosome Therapy Technology Forecast
10.3.4 Southeast Asia Market Exosome Therapy Technology Forecast
10.3.5 India Market Exosome Therapy Technology Forecast
10.3.6 Australia Market Exosome Therapy Technology Forecast
10.4 Europe Exosome Therapy Technology Forecast by Country (2026-2031)
10.4.1 Germany Market Exosome Therapy Technology Forecast
10.4.2 France Market Exosome Therapy Technology Forecast
10.4.3 UK Market Exosome Therapy Technology Forecast
10.4.4 Italy Market Exosome Therapy Technology Forecast
10.4.5 Russia Market Exosome Therapy Technology Forecast
10.5 Middle East & Africa Exosome Therapy Technology Forecast by Region (2026-2031)
10.5.1 Egypt Market Exosome Therapy Technology Forecast
10.5.2 South Africa Market Exosome Therapy Technology Forecast
10.5.3 Israel Market Exosome Therapy Technology Forecast
10.5.4 Turkey Market Exosome Therapy Technology Forecast
10.6 Global Exosome Therapy Technology Forecast by Type (2026-2031)
10.7 Global Exosome Therapy Technology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Exosome Therapy Technology Forecast
11 Key Players Analysis
11.1 Codiak BioSciences
11.1.1 Codiak BioSciences Company Information
11.1.2 Codiak BioSciences Exosome Therapy Technology Product Offered
11.1.3 Codiak BioSciences Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Codiak BioSciences Main Business Overview
11.1.5 Codiak BioSciences Latest Developments
11.2 Capricor Therapeutics
11.2.1 Capricor Therapeutics Company Information
11.2.2 Capricor Therapeutics Exosome Therapy Technology Product Offered
11.2.3 Capricor Therapeutics Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Capricor Therapeutics Main Business Overview
11.2.5 Capricor Therapeutics Latest Developments
11.3 Evox Therapeutics
11.3.1 Evox Therapeutics Company Information
11.3.2 Evox Therapeutics Exosome Therapy Technology Product Offered
11.3.3 Evox Therapeutics Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Evox Therapeutics Main Business Overview
11.3.5 Evox Therapeutics Latest Developments
11.4 ExoCarta
11.4.1 ExoCarta Company Information
11.4.2 ExoCarta Exosome Therapy Technology Product Offered
11.4.3 ExoCarta Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ExoCarta Main Business Overview
11.4.5 ExoCarta Latest Developments
11.5 Aegle Therapeutics
11.5.1 Aegle Therapeutics Company Information
11.5.2 Aegle Therapeutics Exosome Therapy Technology Product Offered
11.5.3 Aegle Therapeutics Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aegle Therapeutics Main Business Overview
11.5.5 Aegle Therapeutics Latest Developments
11.6 Aruna Bio
11.6.1 Aruna Bio Company Information
11.6.2 Aruna Bio Exosome Therapy Technology Product Offered
11.6.3 Aruna Bio Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aruna Bio Main Business Overview
11.6.5 Aruna Bio Latest Developments
11.7 NeuroTrauma Sciences
11.7.1 NeuroTrauma Sciences Company Information
11.7.2 NeuroTrauma Sciences Exosome Therapy Technology Product Offered
11.7.3 NeuroTrauma Sciences Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 NeuroTrauma Sciences Main Business Overview
11.7.5 NeuroTrauma Sciences Latest Developments
11.8 THERILLIA
11.8.1 THERILLIA Company Information
11.8.2 THERILLIA Exosome Therapy Technology Product Offered
11.8.3 THERILLIA Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 THERILLIA Main Business Overview
11.8.5 THERILLIA Latest Developments
11.9 Avalon GloboCare
11.9.1 Avalon GloboCare Company Information
11.9.2 Avalon GloboCare Exosome Therapy Technology Product Offered
11.9.3 Avalon GloboCare Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Avalon GloboCare Main Business Overview
11.9.5 Avalon GloboCare Latest Developments
11.10 CellTex Therapeutics
11.10.1 CellTex Therapeutics Company Information
11.10.2 CellTex Therapeutics Exosome Therapy Technology Product Offered
11.10.3 CellTex Therapeutics Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 CellTex Therapeutics Main Business Overview
11.10.5 CellTex Therapeutics Latest Developments
11.11 EVerZom
11.11.1 EVerZom Company Information
11.11.2 EVerZom Exosome Therapy Technology Product Offered
11.11.3 EVerZom Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 EVerZom Main Business Overview
11.11.5 EVerZom Latest Developments
11.12 Lonza
11.12.1 Lonza Company Information
11.12.2 Lonza Exosome Therapy Technology Product Offered
11.12.3 Lonza Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Main Business Overview
11.12.5 Lonza Latest Developments
11.13 ExoCoBio
11.13.1 ExoCoBio Company Information
11.13.2 ExoCoBio Exosome Therapy Technology Product Offered
11.13.3 ExoCoBio Exosome Therapy Technology Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ExoCoBio Main Business Overview
11.13.5 ExoCoBio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂